...In addition, we recommend that the inactive ingredients in the test product formulation be.....Formulation Particle size, morphic form, and state of solvation of an active ingredient.....BACKGROUND Product quality studies provide information that pertains to the identity..
http://www.fda.gov/cder/guidance/5383DFT.doc (score=100)

Draft Guidance for Reviewers: Instructions and Template for Chemistry,...
...You should document and assess any data provided which demonstrate that the product is stable between the time of product.....You should ensure that the sponsor verifies the identity of the MCB and the final product by assays that will identify the product.....You should document whether the final cell harvest is centrifuged prior to final..
http://www.fda.gov/cber/gdlns/cmcsomcell.htm (score=100)

MDI and DPI Drug Products
...an internal reservoir containing sufficient formulation for multiple doses that are.....The guidance sets forth information that should be provided to ensure continuing drug.....formulation, moisture level, consistency of filling operation, particle size distribution..
http://www.fda.gov/cder/guidance/2180dft.pdf (score=48)

Document
...Even minor variations in formulation, effectiveness. formula is stated as: such as the.....product effectiveness. revising the guidelines to state: revising the relative humidity.....A, comment 4 and section statistical analysis that one product is .. misuse by..
http://www.fda.gov/OHRMS/DOCKETS/98fr/03-14140.pdf (score=39)

Pediatric Rule
...younger pediatric populations cannot take the adult formulation, may also deny pediatric.....recognizes that, in some cases, a change to an approved product, particularly a new.....In the development of a new drug or biological product, decisions about appropriate..
http://www.fda.gov/cder/guidance/pedrule.pdf (score=38)

Safety and Effectiveness of New Drugs & Biological Products in Pediatric...
...The applicant may be required to develop a pediatric formulation for a drug product that is indicated for a very.....FDA has tentatively concluded that it would be reasonable to expect a manufacturer of a product to produce a pediatric.....The type of formulation needed would vary depending on the age group in which the product..
http://www.fda.gov/cder/guidance/pedrule.htm (score=38)

FR Doc 03-14140
...Subjects were given a preweighed product and instructed to use only that product, to keep a record of how many times they used it.....Subjects applied the antiperspirant test formulation to one axilla and used either a.....The placebo was identical to the test formulation and supposedly devoid of antiperspirant..
http://www.fda.gov/OHRMS/DOCKETS/98fr/03-14140.htm (score=37)

Recommendations for Complying With the Pediatric Rule (21 CFR 314.55(a) and...
...Under the Pediatric Rule you may be required to produce a pediatric formulation if one is.....Where possible, an estimate of patient exposure to the drug product, with special.....It is usually prudent to begin the development of a pediatric formulation before..
http://www.fda.gov/cder/guidance/3578dft.htm (score=36)

...Under the Pediatric Rule you may be required to produce a pediatric formulation if one is.....Where possible, an estimate of patient exposure to the drug product, with special.....It is usually prudent to begin the development of a pediatric formulation before..
http://www.fda.gov/cder/guidance/3578dft.doc (score=36)

WAIS Document Retrieval
...The comment argued that determination of eye irritancy should be based on total product.....The potential for titanium dioxide particles to agglomerate in formulation, which could.....The agency advises that on or after May 21, 2001, no OTC drug product that is subject to..
http://www.fda.gov/cder/fdama/fedreg/sunscreen.txt (score=36)

...Failure to develop a pediatric formulation of a drug or biological product, where younger pediatric populations cannot take.....Difficulties in developing an adequate pediatric formulation may, in some cases, justify.....As a result, product labeling frequently fails to provide directions for safe and..
http://www.fda.gov/ohrms/dockets/98fr/120298c.txt (score=35)

/a/content.30891
...slight changes in the formulation on product variability, 19.. because they may have made it the same way.....all the clinical data on the to-be-marketed formulation, 6.. even if it is more than one.....product for the first time without doing in vivo testing, 25.. and the answer to that is..
http://www.fda.gov/ohrms/dockets/ac/00/transcripts/3657t2.pdf (score=35)

Document
...methods that optimize safety, safety and effectiveness of the product, studies.....The AAP stated that premature infants, formulation had failed. compound is cleared from.....Vital and Health Statistics, Procedures, Priority Review Policy, product, including a..
http://www.fda.gov/ohrms/dockets/98fr/120298c.pdf (score=35)

...20 Ingress or leaching of such chemicals into 21 drug product formulation poses a safety concern.....12 So, in a nutshell, product contamination 13 can occur because of the formulation.....There are many more 19 proprietary chemicals used in the formulation of 20 these adhesives..
http://www.fda.gov/ohrms/dockets/ac/04/transcripts/2004-4040T1.DOC (score=35)

Guideline for Submitting Supporting Documentation
...An amendment should be filed for any significant changes in formulation not proposed in.....List all substances used in the manufacture of a drug product whether or not they appear.....To facilitate the evaluation of the production and control of the drug product, submit a..
http://www.fda.gov/cder/guidance/drugprod.htm (score=34)

CBER - Workshop on Non-Clinical Safety Evaluation of Preventive Vaccines:...
...Such as, if any significant changes are made to the product and/or the formulation, then there may be.....And then, when we have the toxicology profile of this product, we have also to combine this product with a vaccine and to test.....We know what the clinical formulation is, but if we want to push the dose, should we come..
http://www.fda.gov/cber/minutes/tox120202.htm (score=34)

Guidance for Industry
...Manufacturers should contact the appropriate CBER product office to discuss the.....understanding relationships among various critical formulation and process factors and.....applicability of PAT for their specific product and situation. In collaboration with CBER..
http://www.fda.gov/OHRMS/DOCKETS/98fr/5815dft.pdf (score=34)

Document
...and tribal governments, in the aggregate, the change in formulation, the product, intends to publish a.....that addresses formulation, labeling, rule is consistent with the principles set active.....product contains the following warnings for each ingredient in the combination, listed in..
http://www.fda.gov/cder/otcmonographs/Skin_Protectant/skin_protectant_FM_20030604.pdf (score=34)

FR Doc 04-9652
...The submission of an NDA is necessary to provide FDA with information on the product's formulation.....An application must also include information on the drug product's formulation, manufacture, and.....Because bioactivity relates to product-specific formulation and manufacturing issues, each pancreatic..
http://www.fda.gov/OHRMS/DOCKETS/98fr/04-9652.htm (score=34)

Federal Register: August 14, 1997 (Volume 62, Number 157
...Another study estimated that the levothyroxine content of the old formulation was.....A citizen petition claiming that a particular drug product is not subject to the new drug.....There is evidence that manufacturers continue to make formulation changes to orally..
http://www.fda.gov/cder/fedreg/fr14au97-83.htm (score=34)

Las Vegas Injury Lawyer